Related Experiment Video
Updated: Jun 4, 2026
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas
Marta Brell1, Javier Ibáñez, Ana Felpete
1Department of Neurosurgery, HUSD, Palma de Mallorca, Spain.
Abstract:
Malignant gliomas are characterized by their invasiveness and angiogenesis. Matrix metalloproteinases (MMPs) degrade extracellular matrix and create a more permissive environment for cell invasion. We aimed to investigate for the presence of inter- and intratumoral heterogeneity in MMP-2 messenger RNA (mRNA) expression by means of quantitative analysis and to evaluate its prognostic impact in glioma patients. Representative sections from the center and periphery of tumors resected en bloc were taken fresh for study, stained with hematoxylin/eosin for histological evaluation, and immunohistochemically analyzed for Ki-67. MMP-2 mRNA expression was evaluated by real-time reverse transcriptase polymerase chain reaction (RT-PCR). There was MMP-2 expression in all analyzed tumors. By topographical dissection of surgical specimens, we found no differences in cell proliferation or density but significant differences with regard to MMP-2 mRNA expression between central and peripheral regions, being highest at the center of malignant gliomas. MMP-2 mRNA expression showed no prognostic influence on overall or disease-free survival. Our results demonstrate that MMP-2 is differentially expressed in central and peripheral regions of gliomas. Further studies are necessary to clarify the significance of these findings and their possible relevance in clinical practice.
Insights
Malignant gliomas show varied matrix metalloproteinase-2 (MMP-2) messenger RNA (mRNA) expression between tumor centers and peripheries. This MMP-2 heterogeneity did not impact patient survival, suggesting further research is needed.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Malignant gliomas exhibit invasiveness and angiogenesis, processes influenced by extracellular matrix degradation.
- Matrix metalloproteinases (MMPs), particularly MMP-2, play a role in facilitating tumor cell invasion.
- Understanding intratumoral heterogeneity in MMP expression is crucial for glioma research.
Purpose of the Study:
- To investigate inter- and intratumoral heterogeneity in matrix metalloproteinase-2 (MMP-2) messenger RNA (mRNA) expression in malignant gliomas.
- To quantitatively analyze MMP-2 mRNA expression differences between the central and peripheral regions of gliomas.
- To evaluate the prognostic significance of MMP-2 mRNA expression heterogeneity in glioma patients.
Main Methods:
- Quantitative analysis of MMP-2 mRNA expression using real-time reverse transcriptase polymerase chain reaction (RT-PCR).
- Histological evaluation and Ki-67 immunohistochemical analysis for cell proliferation and density.
- Topographical dissection of surgical specimens to compare central and peripheral tumor regions.
Main Results:
- MMP-2 mRNA expression was detected in all analyzed malignant gliomas.
- Significant differences in MMP-2 mRNA expression were observed between central and peripheral tumor regions, with higher expression at the center.
- No significant differences in cell proliferation or density were found between central and peripheral regions.
- MMP-2 mRNA expression levels did not show a prognostic influence on overall or disease-free survival.
Conclusions:
- Malignant gliomas exhibit differential MMP-2 mRNA expression between their central and peripheral regions.
- The observed intratumoral heterogeneity in MMP-2 mRNA expression requires further investigation.
- The clinical relevance and prognostic impact of MMP-2 heterogeneity in gliomas remain to be elucidated.
